The Enterprise Value as of September 2024 (TTM) for VentriPoint Diagnostics Ltd. (VPTDF) is 29.56M

According to VentriPoint Diagnostics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 29.56M. This represents a change of -20.70% compared to the average of 37.28M of the last 4 quarters.

VentriPoint Diagnostics Ltd. (VPTDF) Historical Enterprise Value (quarterly & annually)

How has VPTDF Enterprise Value performed in the past?

The mean historical Enterprise Value of VentriPoint Diagnostics Ltd. over the last ten years is 17.14M. The current 29.56M Enterprise Value has changed 17.14% with respect to the historical average. Over the past ten years (40 quarters), VPTDF's Enterprise Value was at its highest in in the September 2021 quarter at 64.25M. The Enterprise Value was at its lowest in in the June 2020 quarter at 1.26M.

VentriPoint Diagnostics Ltd. (VPTDF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of VentriPoint Diagnostics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

VentriPoint Diagnostics Ltd. (VPTDF) Average Enterprise Value

How has VPTDF Enterprise Value performed in the past?

The current Enterprise Value of VentriPoint Diagnostics Ltd. (VPTDF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

VentriPoint Diagnostics Ltd. (VPTDF) Enterprise Value vs. Peers

How is VPTDF’s Enterprise Value compared to its peers?

VentriPoint Diagnostics Ltd.’s Enterprise Value is greater than Manhattan Scientifics, Inc. (693.14K), less than Cannabix Technologies Inc. (49.00M), less than Accelerate Diagnostics, Inc. (69.43M), less than Venus Concept Inc. (48.91M), less than NeuroPace, Inc. (261.69M), less than Delcath Systems, Inc. (248.68M), less than Surmodics, Inc. (572.56M), less than ProSomnus, Inc. Common Stock (40.81M), less than CVRx, Inc. (166.50M), less than Integra LifeSciences Holdings Corporation (3.17B), less than Monogram Orthopaedics, Inc. (81.26M), less than Axonics, Inc. (3.41B), less than Nano-X Imaging Ltd. (344.95M), less than Medtronic plc (141.75B),

Build a custom stock screener for VentriPoint Diagnostics Ltd. (VPTDF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VentriPoint Diagnostics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

VentriPoint Diagnostics Ltd. (VPTDF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like VentriPoint Diagnostics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.